Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Robert T. Brodell MD, FAAD Editor-in-Chief

Eliot N. Mostow MD, MPH Associate Editor

See All Experts

featured

Published in Dermatology and

Journal Scan / Research · October 20, 2021

Compliance With SLNB Guidelines for Invasive Melanomas Treated With Mohs Micrographic Surgery

Cancer

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Viola Franke MD

Brian Gastman MD

Cancer

Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery

Cancer 2021 Oct 01;127(19)3591-3598, KM MacArthur, BC Baumann, JF Sobanko, JR Etzkorn, TM Shin, HW Higgins, CN Giordano, SL McMurray, A Krausz, JG Newman, K Rajasekaran, SB Cannady, RM Brody, GC Karakousis, JT Miura, JV Cohen, RK Amaravadi, TC Mitchell, LM Schuchter, CJ Miller

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Melanoma

Compliance With SLNB Guidelines for Invasive Melanomas Treated With Mohs Micrographic Surgery

Additional Info

Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery

Further Reading

Efficacy and Safety of Treatment With Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis

Relative Effect of a 0.8-mm Breslow Thickness on the Risk of Death Owing to Melanoma and Other Causes Among Patients With Thin Cutaneous Melanomas

Effectiveness of a Novel Treatment Regimen for Patients With Acne Vulgaris

Efficacy of a Novel Four-Step Skin Care Regimen in Improving Uneven Skin Tone

Outcomes of Treatment With CO2 Laser vs Surgical Deroofing in Patients With Hidradenitis Suppurativa Tunnels

Effectiveness of Treatment With Deucravacitinib in Patients With Plaque, Generalized Pustular, or Erythrodermic Psoriasis

Factors Associated With Maintenance of Clinical Response After Reducing the Dosing Frequency of Tralokinumab in Patients With Moderate to Severe Atopic Dermatitis

Long-Term Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Hidradenitis Suppurativa

Association Between Metformin Use and the Risk of Non-Melanoma Skin Cancer

Allergic Contact Dermatitis Owing to Personal Care Product Use Among Men

Provider-Related Factors Associated With an Increased Likelihood of Performing Benign Skin Biopsies

Recently Updated